Jersey Shore NJ
Behind the Seizure Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy
SAN FRANCISCO, Jan. 8, 2020 /PRNewswire/ -- Today BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Invitae Corporation (NYSE: NVTA) announced that Biogen (NASDAQ: BIIB), Encoded The…
